The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 51.50
Ask: 54.50
Change: -1.50 (-2.75%)
Spread: 3.00 (5.825%)
Open: 53.00
High: 53.00
Low: 53.00
Prev. Close: 54.50
BVT Live PriceLast checked at -
Baronsmead Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

4 Aug 2021 15:07

RNS Number : 6010H
Baronsmead Venture Trust PLC
04 August 2021
 

 

4 August 2021

 

 

Baronsmead Venture Trust plc

("BVT" or the "Company")

 

Appointment of Non-Executive Director

 

The Board of Baronsmead Venture Trust plc is pleased to announce the appointment of Ms Fiona Miller Smith as an independent Non-Executive Director of the Company and a member of the Audit Committee, Management Engagement & Remuneration Committee and Nomination Committee, with effect from 1 September 2021.

Ms Miller Smith is CEO of Barts Charity ("Barts"), a health foundation with a £500m financial investment and commercial property portfolio. Barts funds transformational medical research and innovation in healthcare delivery and technology. Fiona has over twenty five years' experience of investing in and leading growth companies. Her early career was in finance and private equity and she then had a successful entrepreneurial career prior to joining Barts in 2016.

Peter Lawrence, Chairman of the Company, commented on the appointment:

"I am delighted that Fiona has agreed to join us and welcome her to an already talented board. Her extensive knowledge and experience of early stage investing, ESG matters, and board governance will be of great benefit to us. I am confident that her contribution will be of substantial value as we grow and continue to steer our successful VCT with optimism, through the uncertain times ahead."

 

There are no further items requiring disclosure under Listing Rule 9.6.13 regarding Ms Miller Smith's appointment.

 

 

 

 

For further information, please contact:

 

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com

 

LEI: 213800VQ1PQHOJXDDQ88

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZLFBFVLBBBE
Date   Source Headline
7th Aug 201810:00 amRNSNet Asset Value(s)
13th Jul 20182:00 pmRNSNet Asset Value(s)
11th Jul 201812:27 pmRNSDirector Declaration
2nd Jul 20184:22 pmRNSTotal Voting Rights
28th Jun 20185:00 pmRNSTransaction in Own Shares
6th Jun 20184:30 pmRNSNet Asset Value(s)
1st Jun 201811:20 amRNSTotal Voting Rights
30th May 201811:38 amRNSTransaction in Own Shares
25th May 20187:00 amRNSHalf-year Report
14th May 20182:20 pmRNSDirector Declaration
4th May 20184:30 pmRNSNet Asset Value(s)
12th Apr 20183:00 pmRNSNet Asset Value(s)
3rd Apr 20181:02 pmRNSTotal Voting Rights
28th Mar 20185:39 pmRNSTransaction in Own Shares
6th Mar 20184:00 pmRNSNet Asset Value(s)
21st Feb 20183:15 pmRNSResult of AGM
7th Feb 201810:00 amRNSNet Asset Value(s)
18th Jan 201812:30 pmRNSNet Asset Value(s)
17th Jan 20183:30 pmRNSDirectorate Change
2nd Jan 20185:46 pmRNSTotal Voting Rights
20th Dec 20175:35 pmRNSTransaction in Own Shares
7th Dec 20172:30 pmRNSNet Asset Value(s)
5th Dec 20172:41 pmRNSDirectorate Change
1st Dec 201710:30 amRNSTotal Voting Rights
29th Nov 20175:29 pmRNSPublication of a supplementary prospectus
21st Nov 20176:00 pmRNSTransaction in Own Shares
21st Nov 20177:00 amRNSAnnual Financial Report
10th Nov 20174:15 pmRNSIssue of New Shares
7th Nov 20175:00 pmRNSNet Asset Value(s)
6th Nov 201711:15 amRNSOffer for Subscription - Update
1st Nov 20175:34 pmRNSDirector/PDMR Shareholding
1st Nov 20171:15 pmRNSTotal Voting Rights
26th Oct 20174:30 pmRNSIssue of New Shares
11th Oct 20175:30 pmRNSNet Asset Value(s)
4th Oct 20175:03 pmRNSPublication of a Prospectus - Replacement
4th Oct 20174:30 pmRNSPublication of a Prospectus
2nd Oct 20177:00 amRNSTotal Voting Rights
27th Sep 20175:32 pmRNSTransaction in Own Shares
25th Sep 20174:30 pmRNSUpdate on Fundraising
20th Sep 20175:35 pmRNSCancellation of Share Premium Account
6th Sep 20172:30 pmRNSNet Asset Value(s)
4th Aug 20174:00 pmRNSNet Asset Value(s)
2nd Aug 20175:00 pmRNSIntention to Fundraise
13th Jul 201712:00 pmRNSNet Asset Value(s)
3rd Jul 201712:00 pmRNSTotal Voting Rights
29th Jun 20175:22 pmRNSTransaction in Own Shares
20th Jun 20177:00 amRNSDirector/PDMR Shareholding
6th Jun 20174:00 pmRNSNet Asset Value(s)
1st Jun 201711:00 amRNSTotal Voting Rights
24th May 20175:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.